canertinib has been researched along with fluorouracil in 2 studies
Studies (canertinib) | Trials (canertinib) | Recent Studies (post-2010) (canertinib) | Studies (fluorouracil) | Trials (fluorouracil) | Recent Studies (post-2010) (fluorouracil) |
---|---|---|---|---|---|
124 | 9 | 65 | 45,562 | 9,307 | 14,663 |
Protein | Taxonomy | canertinib (IC50) | fluorouracil (IC50) |
---|---|---|---|
Epidermal growth factor receptor | Homo sapiens (human) | 0.32 | |
Thymidylate synthase | Mus musculus (house mouse) | 1.58 | |
Aromatase | Homo sapiens (human) | 0.63 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (50.00) | 24.3611 |
2020's | 1 (50.00) | 2.80 |
Authors | Studies |
---|---|
Aydinlik, S; Dere, E; Ulukaya, E | 1 |
Ju, WT; Liang, SY; Tang, X; Zhang, ZY; Zhao, TC; Zhong, LP; Zhou, ZH; Zhu, DW | 1 |
2 other study(ies) available for canertinib and fluorouracil
Article | Year |
---|---|
Induction of autophagy enhances apoptotic cell death via epidermal growth factor receptor inhibition by canertinib in cervical cancer cells.
Topics: Antineoplastic Agents; Apoptosis; Cell Proliferation; Drug Screening Assays, Antitumor; ErbB Receptors; Female; Fluorouracil; HeLa Cells; Humans; Membrane Potential, Mitochondrial; Morpholines; Organometallic Compounds; Protein Kinase Inhibitors; Uterine Cervical Neoplasms | 2019 |
Mechanism of sensitivity to cisplatin, docetaxel, and 5-fluorouracil chemoagents and potential erbB2 alternatives in oral cancer with growth differentiation factor 15 overexpression.
Topics: Animals; Antineoplastic Combined Chemotherapy Protocols; Apoptosis; Caspase 9; Cell Line, Tumor; Cell Proliferation; Cell Transformation, Neoplastic; Cisplatin; Fluorouracil; Growth Differentiation Factor 15; Humans; Mice; Morpholines; Mouth Neoplasms; Phosphorylation; Receptor, ErbB-2; Signal Transduction; Squamous Cell Carcinoma of Head and Neck; Taxoids | 2022 |